CFAR Adelante program funding is provided by the US National Institutes of Health as a supplement to the District of Columbia CFAR (P30AI117970) and the Emory University CFAR (P30AI050409). Adelante awards are contingent on the availability of funds from this source.

Funding permitting, we anticipate making up to four awards in the next round (Cohort IV; 8/1/2021-7/31/2023). Awards are funded for two years and are non-renewable.

Applicants may request up to $75,000 in direct costs per year plus applicable indirect costs, not to exceed $150,000 in total (direct + applicable indirect) costs.

Funding may be used for salaries, technical support, laboratory supplies, equipment, and for research- or training-related activities including but not limited to enrollment in training classes or workshops, travel to the CFAR Mentor's institution, and travel to the research field site.